NCT03333343 2026-01-16Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLCNovartisPhase 1 Active not recruiting105 enrolled
NCT03740334 2025-11-21Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALLDana-Farber Cancer InstitutePhase 1 Active not recruiting45 enrolled
NCT02608216 2025-09-03[18F]FLT PET/CT in Rb+ Metastatic Breast CancerUniversity of PennsylvaniaPhase 1 Active not recruiting20 enrolled